awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33899917-9ED31A0A-4DAC-45BA-94FB-7E1F5CE4AF73
Q33899917-9ED31A0A-4DAC-45BA-94FB-7E1F5CE4AF73
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33899917-9ED31A0A-4DAC-45BA-94FB-7E1F5CE4AF73
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.
P2860
Q33899917-9ED31A0A-4DAC-45BA-94FB-7E1F5CE4AF73
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33899917-9ED31A0A-4DAC-45BA-94FB-7E1F5CE4AF73
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
16fc91c5f034009c2de1caedaac57b6e5d1aa9be
P2860
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients